drugset / Trial / NCT02965859

The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B

NCT02965859

Phase 2 Unknown 180 enrolled Guangzhou Yipinhong Pharmaceutical CO.,LTD
RandomizedParallel-groupDouble-blindTreatment

Summary

The study objective is to evaluate the safety and effectiveness of different doses of Metacavir Enteric-coated Capsules in treatment of chronic hepatitis B,as well as to find an appropriate clinical dosage by comparing the effect of different doses of treatment,in order to provide references of clinical trial of the next phase.

Timeline

Start
2012-12
Primary completion
2018-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adefovir dipivoxil Small molecule 10 mg
Subject Metacavir Small molecule 80 mg
Subject Metacavir Small molecule 160 mg
Subject Metacavir Small molecule 320 mg